Establish AGO patient registry & natural history study

AGO1/2 Natural History Study by Prof. Lessel

What is a Natural History Study?

The aim of a natural history study (NHS) is to understand the course of the disease better: 

Why does it matter?

With this study, we can

The last point is crucial for rare diseases with small patient populations. It means that everyone in the study can receive the treatment, and no one receives a placebo - while still being able to measure whether the drug works!!

Join the study

This is THE most important thing you can do today to help your child.

A high level of patient participation is essential to get a representative picture. Every single patient experience counts. 

The AGO1/2 NHS is led and sponsored by Prof. Lessel at University Hospital Salzburg. If you want to take part, please email Dr. Olena Ielesicheva.

Join the study

The questionnaire is currently available in English, German, Spanish and Italian. Please use e.g. deepl.com to translate it into other languages and contact Dr. Ielesicheva in case of doubt.

Epilepsy deep-dive

Prof. Piton leads a follow-up study on epilepsy, which affects ~50% of AGO children. This will help to understand the different types and whether this could be used as a diagnostic tool or to study effects of future treatments.

You can participate by sending information from the clinical reports of the consultations with child neurologists, and indicate any anti-seizure medication.

Please send a physical copy to the address below or contact Dr. Sarah Baer or Dr. Amélie Piton for more information (sarah.baer@chru-strasbourg.fr - apiton@unistra.fr). You can mask the child’s name in the report, except the first 3 letters.

Sarah Baer/Amelie Piton
IGBMC
1 rue Laurent Fries
67 400 illkirch
France

Confused? Additional questions?

Please reach out to Dr. Ielesicheva or us!